Is Dipna Pharmachem Ltd (543594) a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Dipna Pharmachem Ltd is a below average quality company .

Is Dipna Pharmachem Ltd (543594) undervalued or overvalued?

The key valuation ratios of Dipna Pharmachem Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone .

What is Dipna Pharmachem Ltd (543594) share price return in the past 10 years?

Data is not available for this company

Is Dipna Pharmachem Ltd (543594) a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Dipna Pharmachem Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

What is the share price of Dipna Pharmachem Ltd (543594)?

Company share prices are keep on changing according to the market conditions. The current trading price of Dipna Pharmachem Ltd (543594) on 10-Apr-2026 16:59:59 at 16:59 is 9.43.

What is the P/E ratio of Dipna Pharmachem?

The latest standalone P/E ratio of Dipna Pharmachem as of 10-Apr-2026 is 25.45.

What is the P/B ratio of Dipna Pharmachem Ltd (543594)?

The latest standalone P/B ratio of Dipna Pharmachem Ltd (543594) as of 10-Apr-2026 is 0.60.

What is the 52-week high and low of Dipna Pharmachem Ltd (543594)?

The 52-week high of Dipna Pharmachem Ltd (543594) is Rs. 26.31 and the 52-week low is Rs. 7.45.

Dipna Pharmachem Ltd (543594) Share Analysis – Quality, Valuation Zone & Price Trend & DeciZen Rating

Name: Dipna Pharmachem Ltd (543594)
Brand: Dipna Pharmachem

Dipna Pharmachem Ltd (543594) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Key Metrics

Market Cap

₹25 Cr.

P/E Ratio

25.45

Price to Book (P/B)

0.60

Price to Sales (P/S)

0.20

EV/EBITDA

10.58

Return on Capital Employed (ROCE)

6.95%

Current Price

₹9.4

Return on Equity (ROE)

2.56%

Return on Assets (ROA)

0.73%

Operating Profit Margin

3.1%

Net Profit Margin

0.78%

Gross Profit Margin

1.2%

Book Value per Share

₹15.8

Sales Growth (YoY)

-23.99%

Sales Growth (3 Years)

19.74%

Operating Profit Growth (1 Year)

12%

Operating Profit Growth (3 Years)

20.15%

Net Profit Growth (1 Year)

-11.01%

52-Week Low / High

₹7 / 26

Net Profit Growth (3 Years)

-97.97%

Dividend Yield

0.00%

Promoter Holding

9.98%

Pledged shares (%)
of Promoter's holding (%)

0.00%

Check Before You Invest

Q.1

Dipna Pharmachem Ltd belongs to the Miscellaneous sector, operating specifically within the Trading segment.

Q.1 Gross Profit margin of Dipna Pharmachem Ltd?

Dipna Pharmachem Ltd Gross profit margin which is the profit after deduction of direct costs, is 1.2% for FY-2025 , which is above its 5 year median of 0% , indicating increasing margins.

Q.1 Promoter shareholding and pledge status of Dipna Pharmachem Ltd?

Promoters hold 9.98% of the Dipna Pharmachem Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Revenue growth of Dipna Pharmachem Ltd vs industry peers?

Dipna Pharmachem Ltd revenue CAGR is 32.54% , compared to the industry median CAGR of 17.75% , indicating faster growth and gaining its market share.

Q.1 Stock return of Dipna Pharmachem Ltd over the last decade?

Over the last 9 years, the stock has delivered a CAGR of 0% based on the current price.

Q.1 Is Dipna Pharmachem Ltd a good quality company?

Dipna Pharmachem Ltd is a quality company, based on a 10 year financial track record .

DeciZen - make an informed investing decision on Dipna Pharma.

Based on:

Data

M-Cap below 100cr DeciZen not available

Dipna Pharmachem stock performance

Key Ratios

Is Dipna Pharmachem Ltd an attractive stock to invest in?

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	7.2%	8%	5.4%	3.5%	18.2%	9.2%	7.2%	7%	-
Value Creation Index ⓘ	-0.5	-0.4	-0.6	-0.8	0.3	-0.4	-0.5	-0.5	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	16.6	20.2	30.5	31	72.8	99.9	164	125	125
Sales YoY Gr.	-	21.9%	51.3%	1.5%	134.7%	37.3%	64.5%	-24%	-
Adj EPS ⓘ	3.5	5	4.4	1.2	57.1	0.6	0.5	0.4	0.4
YoY Gr.	-	43.4%	-12.8%	-72.9%	4736.4%	-98.9%	-28.6%	-8.9%	-
BVPS (₹) ⓘ	22.3	23.9	26.8	28	85	16.7	15.6	16	15.8
Adj Net Profit ⓘ	0.1	0.1	0.1	0	1.2	0.9	1.1	1	1
Cash Flow from Ops. ⓘ	0	0	-3.1	-2.4	2.8	-21	-5.4	-9.2	-
Debt/CF from Ops. ⓘ	0	0	-3.1	-5.1	3.6	-0.8	-3.6	-1.9	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	32.5%	19.7%	-24%
Adj EPS ⓘ	NA	-37.7%	-80.7%	-8.9%
BVPSⓘ	NA	-9.8%	-42.7%	2.6%
Share Price	-	-	-10.5%	-42.7%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	15.6	21.6	17.2	4.3	101	7	3.5	2.6	2.3
Op. Profit Mgn % ⓘ	2.4	2.9	1.6	1.3	3.1	2.4	2.1	3.1	NAN
Net Profit Mgn % ⓘ	0.4	0.5	0.3	0.1	1.6	0.9	0.7	0.8	0.8
Debt to Equity ⓘ	11.2	12.3	17.5	21.7	5.9	0.7	0.5	0.5	-
Working Cap Days ⓘ	0	223	192	252	152	197	212	367	0
Cash Conv. Cycle ⓘ	0	74	83	115	47	49	15	-41	0

Recent Performance Summary

Latest Financials

	Standalone	Consolidated
TTM EPS (₹)	0.4	-
TTM Sales (₹ Cr.)	125	-
BVPS (₹) ⓘ	15.8	-
Reserves (₹ Cr.) ⓘ	15	-
P/BV ⓘ	0.60	-
PE ⓘ	25.45	-

From the Market
52 Week Low / High (₹)	7.45 / 26.31
All Time Low / High (₹)	6.40 / 27.61
Market Cap (₹ Cr.)	24.8
Equity (₹ Cr.)	26.3
Face Value (₹)	10
Industry PE ⓘ	24.2

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Dipna Pharma. - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	16.56	20.18	30.54	31	72.76	99.93	164.34	124.92
Operating Expenses ⓘ +	16.17	19.70	30.09	30.60	70.50	97.53	160.83	121
Manufacturing Costs	1.46	0.44	0.08	0.06	0.41	0.13	0.09	0.10
Material Costs	14.17	18.53	28.94	29.58	68.56	95.49	157.91	113.73
Employee Cost	0.26	0.35	0.38	0.41	0.62	0.45	0.45	0.42
Other Costs ⓘ	0.28	0.37	0.68	0.55	0.91	1.46	2.38	6.76
Operating Profit ⓘ	0.38	0.48	0.45	0.40	2.26	2.40	3.50	3.92
Operating Profit Margin (%)	2.3%	2.4%	1.5%	1.3%	3.1%	2.4%	2.1%	3.1%
Other Income ⓘ +	0.01	0.01	0.01	0.02	0.01	0.01	0	0.01
Exceptional Items ⓘ	0	0	0	0	0	0	0	0
Interest ⓘ	0.33	0.43	0.39	0.35	0.69	1.01	2.07	2.50
Depreciation ⓘ	0	0.01	0.01	0.01	0.01	0.01	0.02	0.01
Profit Before Tax ⓘ	0.07	0.06	0.06	0.06	1.57	1.38	1.42	1.42
Tax ⓘ	0.01	0.02	0	0.03	0.41	0.47	0.33	0.45
Profit After Tax	0.06	0.03	0.06	0.02	1.17	0.91	1.09	0.97
PAT Margin (%)	0.4%	0.2%	0.2%	0.1%	1.6%	0.9%	0.7%	0.8%
Adjusted EPS (₹)	3.0	1.6	2.9	1.2	57.1	0.6	0.5	0.4
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	0.46	0.49	0.55	0.57	1.74	24.36	37.52	38.49
Share Capital ⓘ	0.04	0.04	0.04	0.04	0.04	11.97	24.05	24.05
Reserves ⓘ	0.42	0.45	0.51	0.54	1.70	12.39	13.47	14.45
Debt +	5.10	6.01	9.57	12.43	10.19	15.91	19.45	17.22
Long Term Debt	0	0	3.36	3.68	5.80	10.97	12.55	8.89
Short Term Debt	5.10	6.01	6.21	8.74	4.39	4.94	6.90	8.33
Minority Interest	0	0	0	0	0	0	0	0
Trade Payables	5.50	7.53	8.31	11.78	23.03	36.28	74.54	75.73
Others Liabilities ⓘ	0.03	0.03	0.01	0.02	1.27	1.01	1.40	0.94
Total Liabilities ⓘ	11.08	14.06	18.44	24.79	36.23	77.56	132.90	132.38
Fixed Assets
Net Fixed Assets ⓘ +	0.01	0.05	0.04	0.04	0.04	0.04	0.04	0.05
Gross Block	0.01	0.07	0.07	0.07	0.08	0.09	0.11	0.13
Accumulated Depreciation	0.01	0.02	0.03	0.03	0.04	0.05	0.07	0.08
CWIP ⓘ	0	0	0	0	0	0	0	0
Investments ⓘ	0	0	0	0	0	0	0	0
Inventories	4.35	3.34	5.55	7.20	6.30	18.94	37.38	27.43
Trade Receivables	6	8.85	11.20	14.95	26.97	28.53	30.94	46.28
Cash Equivalents	0.30	0.12	0.18	0.25	0.21	5.69	13.88	0.43
Others Assets ⓘ	0.44	1.71	1.47	2.36	2.70	24.35	50.67	58.19
Total Assets ⓘ	11.08	14.06	18.44	24.79	36.23	77.56	132.90	132.38

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	-3.12	-2.43	2.81	-20.98	-5.42	-9.19
PBT ⓘ	0.06	0.06	1.57	1.38	1.42	1.42
Adjustment ⓘ	0.39	0.35	0.61	0.97	2.01	2.03
Changes in Working Capital ⓘ	-3.57	-2.82	1.03	-22.86	-8.51	-12.2
Tax Paid ⓘ	-0	-0.02	-0.41	-0.47	-0.34	-0.45
Cash Flow From Investing Activity ⓘ +	0.01	0	-0.01	-0.01	-0.01	-0.02
Capex	-0	-0.01	-0.01	-0.01	-0.01	-0.02
Net Investments	0	0	0	0	0	0
Others ⓘ	0.01	0.01	0	0	0	0
Cash Flow From Financing Activity ⓘ +	3.17	2.50	-2.84	26.47	13.62	-4.24
Net Proceeds from Shares ⓘ	0	0	0	21.71	12.08	0
Net Proceeds from Borrowing ⓘ	0.51	0.32	-0.36	0	0	-3.66
Interest Paid ⓘ	-0.39	-0.35	-0.61	-0.96	-2	-2.02
Dividend Paid ⓘ	0	0	0	0	0	0
Others ⓘ	3.05	2.53	-1.88	5.72	3.54	1.43
Net Cash Flow ⓘ	0.06	0.08	-0.04	5.48	8.19	-13.45

Finance Ratio

PARTICULARS	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	13.24	6.78	11.39	4.32	101.02	6.99	3.51	2.56
ROCE (%)	7.16	7.98	5.42	3.54	18.16	9.17	7.18	6.95
Asset Turnover Ratio	1.49	1.61	1.88	1.43	2.38	1.76	1.56	0.94
PAT to CFO Conversion(x)	0	0	-52	-121.5	2.4	-23.05	-4.97	-9.47
Working Capital Days
Receivable Days	132	134	120	154	105	101	66	113
Inventory Days	96	69	53	75	34	46	63	95
Payable Days	142	128	100	124	93	113	128	241

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Dipna Pharmachem Ltd FAQs

The current trading price of Dipna Pharma. on 10-Apr-2026 16:59 is ₹9.43.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 09-Apr-2026 the market cap of Dipna Pharma. stood at ₹24.79 Cr

The latest P/E ratio of Dipna Pharma. as of 09-Apr-2026 is 25.45.

The latest P/B ratio of Dipna Pharma. as of 09-Apr-2026 is 0.60.

The 52-week high of Dipna Pharma. is ₹26.31 and the 52-week low is ₹7.45.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Dipna Pharma. is ₹125 ( Cr.) .

About Dipna Pharmachem Ltd

The company was originally incorporated as “Dipan Pharmachem Private Limited” under the provisions of Companies Act, 1956 vide Certificate of Incorporation dated July 19, 2011 bearing Corporate Identification Number issued by the Registrar of Companies, Gujarat, Dadra and Nagar Havelli. Subsequently, the name of company was changed to “Dipna Pharmachem Private Limited” and a fresh certificate of incorporation was issued by Registrar of Companies, Gujarat, Dadra and Nagar Havelli on March 29, 2012. After that, the Company was converted from Private limited to Public Limited company pursuant to a special resolution passed by shareholders at the EGM held on May 13, 2022 and consequently the name of Company was changed as “Dipna Pharmachem Limited” and a fresh certificate of incorporation was issued by the Registrar of Companies, Ahmedabad dated May 25, 2022.

The company is engaged in the trading and distribution of wide range of pharmaceutical raw material which is also known as APIs (Active Pharmaceutical Ingredients), Excipient and chemical formulation products. Presently its product portfolio comprises of 61 AIPs and AIPs intermediates such as Cephalosporins, Cardiovasculars, Anti - Bactaria, Quinolones, Veterinary, Anti - Virus, Anti - Inflammatory, Neuropsychiatry, Steroid Hormone, other etc. Being a trading and distribution company, it has pan India market for its products. The company had also started the selling of chemicals on commission basis. In the financial year 2022, the company had earned commission income of Rs 127.50 lakh. The company is doing trading in Ahmedabad and surrounding area of Ahmedabad.

Business area of the company

Dipna Pharmachem is a trader, importer, and exporter in industrial Chemical and Pharmaceutical Raw materials, APIs, solvents, and Formulation since 2011. The company’s huge portfolio includes expertise for marketing and sourcing of industrial Chemical and Pharmaceutical Raw materials, APIs, solvents, and Formulation and intermediates, assistance in setting up contract manufacturing compliance for regulated, semi-regulated pharmaceutical companies with all the global benchmark parameters of leading certificates like WHO-GMP.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Dipna Pharmachem Ltd (543594) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Dipna Pharma. Share Price